Transforming Clinical Trial Recruitment and Diagnosis
AI Oncology Tools Shine at ASCO Breakthrough 2026
New clinical AI identifies trial patients and predicts pancreatic cancer outcomes during Singapore's major summit.
A modern medical conference setting featuring large digital displays of AI-driven cancer research and a group of oncologists observing a clinical presentation.
Photo: Avantgarde News
The 2026 ASCO Breakthrough meeting in Singapore highlighted significant progress in clinical artificial intelligence [1]. Researchers presented tools that automatically identify eligible patients for clinical trials to speed up research [1]. These innovations aim to streamline complex medical workflows in global oncology centers [3].
New multi-modal AI models are now predicting how pancreatic cancer patients respond to specific treatments [1]. Beyond AI, the summit showcased advancements in cellular therapy and antibody-drug conjugates [2]. These combined technologies represent a shift toward more personalized cancer care [2][3].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
Related stories
View all
Topics
About the author
Avantgarde News Desk covers transforming clinical trial recruitment and diagnosis and editorial analysis for Avantgarde News.